Ontology of Drug Adverse Events
181 terms(s) returned
| Term Type: | Record: 1 to 50 of 181 Records | Page: 1 of 4, First Previous Next Last | Show Records Per Page |
- D [Preparations]
- DAPSONE
- DAPTOMYCIN
- DASATINIB
- DEFEROXAMINE
- DELAVIRDINE
- DESIPRAMINE
- DEXAMETHASONE
- DIDANOSINE
- DILTIAZEM
- DNA Integrity Alteration [PE]
- DNA Replication Alteration [PE]
- DNA Virus Infections [Disease/Finding]
- DOCETAXEL
- DOXORUBICIN
- Dapsone [Chemical/Ingredient]
- Daptomycin [Chemical/Ingredient]
- Daunorubicin [Chemical/Ingredient]
- Decreased Adhesion Factor Activity [PE]
- Decreased Blood Pressure [PE]
- Decreased Bradykinin Degradation [PE]
- Decreased Brain Stem Organized Electrical Activity [PE]
- Decreased Brain Stem Substance P Activity [PE]
- Decreased Capillary Permeability [PE]
- Decreased Cell Membrane Integrity [PE]
- Decreased Cell Membrane Synthesis & Repair [PE]
- Decreased Cell Wall Integrity [PE]
- Decreased Cell Wall Synthesis & Repair [PE]
- Decreased Cellular Migration [PE]
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- Decreased Central Nervous System Glutamate Activity [PE]
- Decreased Central Nervous System Organized Electrical Activity [PE]
- Decreased Central Nervous System Substance P Activity [PE]
- Decreased Cholesterol Synthesis [PE]
- Decreased Coagulation Activity [PE]
- Decreased Complement Activity [PE]
- Decreased Complement Production [PE]
- Decreased Cytokine Activity [PE]
- Decreased Cytokine Production [PE]
- Decreased DNA Integrity [PE]
- Decreased DNA Replication [PE]
- Decreased Disorganized Electrical Activity [PE]
- Decreased Dopamine Activity [PE]
- Decreased Eicosanoid Activity [PE]
- Decreased Eicosanoid Production [PE]
- Decreased Enteric Nervous System Serotonin Activity [PE]
- Decreased Fibroblast Migration [PE]
- Decreased Folic Acid Modification [PE]
- Decreased Glucocorticoid Secretion [PE]
- Decreased Gluconeogenesis [PE]
